Singapore markets close in 4 hours 27 minutes

PFE Feb 2024 38.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.01000.0000 (0.00%)
As of 03:59PM EST. Market open.
Full screen
Previous close0.0100
Open0.0100
Bid0.0000
Ask0.0100
Strike38.00
Expiry date2024-02-16
Day's range0.0100 - 0.0100
Contract rangeN/A
Volume16
Open interest354
  • Zacks

    Pfizer's (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod

    The approval for Pfizer's (PFE) Velsipity (etrasimod) is based on data from two pivotal phase III studies, ELEVATE UC 52 and ELEVATE 12.

  • Reuters

    UPDATE 3-Pfizer inflammatory bowel disease drug wins EU approval

    Pfizer's drug to treat patients with an inflammatory bowel disease called ulcerative colitis has been approved by the European Commission, the company said on Monday. The approval for Velsipity follows backing from the European Medicines Agency's panel of experts in December. The drug was approved for use in patients aged 16 or older and who did not show adequate response or were intolerant to previous treatment, Pfizer said.

  • Reuters

    CORRECTED-UPDATE 1-Pfizer inflammatory bowel disease drug wins EU approval

    Pfizer's drug to treat patients with an inflammatory bowel disease called ulcerative colitis has been approved by the European Commission, the company said on Monday. The approval for Velsipity follows backing from the European Medicines Agency's panel of experts in December. The drug was approved for use in patients aged 16 or older and who did not show adequate response or were intolerant to previous treatment, Pfizer said.